Immune Checkpoint Inhibitor Exposure in Pregnancy: A Scoping Review

Since their approval, immune checkpoint inhibitors (ICIs) have become the standard of care for multiple malignancies. ICIs enhance tumor destruction by blocking important immunomodulatory pathways that regulate T-cell activation. These pathways include programmed cell death protein-1 and its ligands...

Descripción completa

Detalles Bibliográficos
Autores principales: Salehi, Iman, Porto, Ludmila, Elser, Christine, Singh, Jessica, Saibil, Samuel, Maxwell, Cynthia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Clinical Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087868/
https://www.ncbi.nlm.nih.gov/pubmed/35353074
http://dx.doi.org/10.1097/CJI.0000000000000418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087868/
https://www.ncbi.nlm.nih.gov/pubmed/35353074
http://dx.doi.org/10.1097/CJI.0000000000000418

Ejemplares similares